nodes	percent_of_prediction	percent_of_DWPC	metapath
Temazepam—CYP2C8—Paclitaxel—ovarian cancer	0.0251	0.212	CbGbCtD
Temazepam—CYP3A4—Topotecan—ovarian cancer	0.0206	0.174	CbGbCtD
Temazepam—TSPO—oviduct—ovarian cancer	0.0184	0.0852	CbGeAlD
Temazepam—CYP2B6—Doxorubicin—ovarian cancer	0.0179	0.151	CbGbCtD
Temazepam—CYP2C9—Paclitaxel—ovarian cancer	0.0175	0.148	CbGbCtD
Temazepam—CYP3A4—Vinorelbine—ovarian cancer	0.0145	0.122	CbGbCtD
Temazepam—CYP3A4—Paclitaxel—ovarian cancer	0.0102	0.0859	CbGbCtD
Temazepam—CYP3A4—Docetaxel—ovarian cancer	0.00737	0.0621	CbGbCtD
Temazepam—GABRP—uterine cervix—ovarian cancer	0.00642	0.0298	CbGeAlD
Temazepam—GABRE—myometrium—ovarian cancer	0.0063	0.0292	CbGeAlD
Temazepam—GABRP—decidua—ovarian cancer	0.00612	0.0284	CbGeAlD
Temazepam—TSPO—myometrium—ovarian cancer	0.00588	0.0273	CbGeAlD
Temazepam—GABRP—endometrium—ovarian cancer	0.00581	0.0269	CbGeAlD
Temazepam—TSPO—embryo—ovarian cancer	0.00566	0.0262	CbGeAlD
Temazepam—GABRG3—testis—ovarian cancer	0.00561	0.026	CbGeAlD
Temazepam—CYP3A4—Doxorubicin—ovarian cancer	0.0055	0.0463	CbGbCtD
Temazepam—GABRP—uterus—ovarian cancer	0.00535	0.0248	CbGeAlD
Temazepam—GABRR1—testis—ovarian cancer	0.00535	0.0248	CbGeAlD
Temazepam—GABRE—uterine cervix—ovarian cancer	0.0049	0.0227	CbGeAlD
Temazepam—GABRB1—vagina—ovarian cancer	0.00486	0.0225	CbGeAlD
Temazepam—GABRP—female reproductive system—ovarian cancer	0.00481	0.0223	CbGeAlD
Temazepam—GABRE—decidua—ovarian cancer	0.00467	0.0217	CbGeAlD
Temazepam—GABRD—testis—ovarian cancer	0.00465	0.0215	CbGeAlD
Temazepam—TSPO—epithelium—ovarian cancer	0.00462	0.0214	CbGeAlD
Temazepam—TSPO—uterine cervix—ovarian cancer	0.00458	0.0212	CbGeAlD
Temazepam—GABRE—endometrium—ovarian cancer	0.00443	0.0206	CbGeAlD
Temazepam—TSPO—decidua—ovarian cancer	0.00436	0.0202	CbGeAlD
Temazepam—GABRP—vagina—ovarian cancer	0.00435	0.0202	CbGeAlD
Temazepam—GABRA5—testis—ovarian cancer	0.00431	0.02	CbGeAlD
Temazepam—TSPO—endometrium—ovarian cancer	0.00414	0.0192	CbGeAlD
Temazepam—GABRR2—lymph node—ovarian cancer	0.00402	0.0187	CbGeAlD
Temazepam—GABRA3—testis—ovarian cancer	0.00401	0.0186	CbGeAlD
Temazepam—TSPO—gonad—ovarian cancer	0.00384	0.0178	CbGeAlD
Temazepam—TSPO—uterus—ovarian cancer	0.00382	0.0177	CbGeAlD
Temazepam—GABRE—female reproductive system—ovarian cancer	0.00367	0.017	CbGeAlD
Temazepam—GABRB3—gonad—ovarian cancer	0.00349	0.0162	CbGeAlD
Temazepam—TSPO—female reproductive system—ovarian cancer	0.00343	0.0159	CbGeAlD
Temazepam—GABRA2—vagina—ovarian cancer	0.00335	0.0155	CbGeAlD
Temazepam—GABRE—female gonad—ovarian cancer	0.00334	0.0155	CbGeAlD
Temazepam—GABRE—vagina—ovarian cancer	0.00332	0.0154	CbGeAlD
Temazepam—GABRB2—testis—ovarian cancer	0.00327	0.0152	CbGeAlD
Temazepam—TSPO—bone marrow—ovarian cancer	0.00324	0.015	CbGeAlD
Temazepam—Tremor—Chlorambucil—ovarian cancer	0.00318	0.0056	CcSEcCtD
Temazepam—TSPO—female gonad—ovarian cancer	0.00312	0.0145	CbGeAlD
Temazepam—Agitation—Chlorambucil—ovarian cancer	0.00312	0.00549	CcSEcCtD
Temazepam—GABRB3—female reproductive system—ovarian cancer	0.00311	0.0144	CbGeAlD
Temazepam—TSPO—vagina—ovarian cancer	0.0031	0.0144	CbGeAlD
Temazepam—Agranulocytosis—Vinorelbine—ovarian cancer	0.00308	0.00544	CcSEcCtD
Temazepam—Alopecia—Topotecan—ovarian cancer	0.00306	0.0054	CcSEcCtD
Temazepam—Visual disturbance—Paclitaxel—ovarian cancer	0.00304	0.00537	CcSEcCtD
Temazepam—Alopecia—Melphalan—ovarian cancer	0.003	0.00529	CcSEcCtD
Temazepam—GABRE—testis—ovarian cancer	0.00296	0.0137	CbGeAlD
Temazepam—Lethargy—Paclitaxel—ovarian cancer	0.00294	0.00519	CcSEcCtD
Temazepam—Nystagmus—Doxorubicin—ovarian cancer	0.00294	0.00519	CcSEcCtD
Temazepam—Convulsion—Chlorambucil—ovarian cancer	0.00294	0.00518	CcSEcCtD
Temazepam—Back pain—Topotecan—ovarian cancer	0.00292	0.00515	CcSEcCtD
Temazepam—Muscle spasms—Topotecan—ovarian cancer	0.0029	0.00512	CcSEcCtD
Temazepam—Hyponatraemia—Paclitaxel—ovarian cancer	0.0029	0.00511	CcSEcCtD
Temazepam—CYP2C8—endometrium—ovarian cancer	0.00284	0.0132	CbGeAlD
Temazepam—Blood alkaline phosphatase increased—Docetaxel—ovarian cancer	0.00281	0.00496	CcSEcCtD
Temazepam—Ageusia—Epirubicin—ovarian cancer	0.0028	0.00494	CcSEcCtD
Temazepam—Confusional state—Chlorambucil—ovarian cancer	0.00279	0.00492	CcSEcCtD
Temazepam—TSPO—testis—ovarian cancer	0.00277	0.0128	CbGeAlD
Temazepam—Ataxia—Paclitaxel—ovarian cancer	0.00271	0.00478	CcSEcCtD
Temazepam—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00271	0.00478	CcSEcCtD
Temazepam—Anorexia—Chlorambucil—ovarian cancer	0.00264	0.00465	CcSEcCtD
Temazepam—Alopecia—Vinorelbine—ovarian cancer	0.00262	0.00462	CcSEcCtD
Temazepam—Ageusia—Doxorubicin—ovarian cancer	0.00259	0.00457	CcSEcCtD
Temazepam—Visual disturbance—Docetaxel—ovarian cancer	0.00258	0.00455	CcSEcCtD
Temazepam—Convulsion—Melphalan—ovarian cancer	0.00256	0.00452	CcSEcCtD
Temazepam—GABRB3—testis—ovarian cancer	0.00251	0.0116	CbGeAlD
Temazepam—Back pain—Vinorelbine—ovarian cancer	0.0025	0.0044	CcSEcCtD
Temazepam—Lethargy—Docetaxel—ovarian cancer	0.0025	0.0044	CcSEcCtD
Temazepam—Hyponatraemia—Docetaxel—ovarian cancer	0.00245	0.00433	CcSEcCtD
Temazepam—CYP2C19—vagina—ovarian cancer	0.00244	0.0113	CbGeAlD
Temazepam—Thrombocytopenia—Topotecan—ovarian cancer	0.00241	0.00425	CcSEcCtD
Temazepam—Decreased appetite—Chlorambucil—ovarian cancer	0.00241	0.00424	CcSEcCtD
Temazepam—Dysarthria—Epirubicin—ovarian cancer	0.0024	0.00423	CcSEcCtD
Temazepam—Fatigue—Chlorambucil—ovarian cancer	0.00239	0.00421	CcSEcCtD
Temazepam—Hyperhidrosis—Topotecan—ovarian cancer	0.00238	0.0042	CcSEcCtD
Temazepam—CYP2B6—gonad—ovarian cancer	0.00236	0.011	CbGeAlD
Temazepam—Thrombocytopenia—Melphalan—ovarian cancer	0.00236	0.00416	CcSEcCtD
Temazepam—Tachycardia—Melphalan—ovarian cancer	0.00235	0.00415	CcSEcCtD
Temazepam—CYP2C8—female reproductive system—ovarian cancer	0.00235	0.0109	CbGeAlD
Temazepam—Anorexia—Topotecan—ovarian cancer	0.00235	0.00414	CcSEcCtD
Temazepam—Vertigo—Vinorelbine—ovarian cancer	0.00232	0.00409	CcSEcCtD
Temazepam—Anorexia—Melphalan—ovarian cancer	0.0023	0.00405	CcSEcCtD
Temazepam—Ataxia—Docetaxel—ovarian cancer	0.0023	0.00405	CcSEcCtD
Temazepam—Palpitations—Vinorelbine—ovarian cancer	0.00228	0.00402	CcSEcCtD
Temazepam—Feeling abnormal—Chlorambucil—ovarian cancer	0.00228	0.00402	CcSEcCtD
Temazepam—Hypotension—Melphalan—ovarian cancer	0.00225	0.00397	CcSEcCtD
Temazepam—Abnormal dreams—Epirubicin—ovarian cancer	0.00225	0.00396	CcSEcCtD
Temazepam—Dysarthria—Doxorubicin—ovarian cancer	0.00222	0.00392	CcSEcCtD
Temazepam—Depression—Paclitaxel—ovarian cancer	0.00222	0.00391	CcSEcCtD
Temazepam—Dyspnoea—Topotecan—ovarian cancer	0.0022	0.00387	CcSEcCtD
Temazepam—GABRA2—lymph node—ovarian cancer	0.00217	0.01	CbGeAlD
Temazepam—Dyspnoea—Melphalan—ovarian cancer	0.00215	0.00379	CcSEcCtD
Temazepam—GABRE—lymph node—ovarian cancer	0.00215	0.00996	CbGeAlD
Temazepam—Decreased appetite—Topotecan—ovarian cancer	0.00214	0.00378	CcSEcCtD
Temazepam—CYP2C8—vagina—ovarian cancer	0.00213	0.00987	CbGeAlD
Temazepam—Fatigue—Topotecan—ovarian cancer	0.00212	0.00374	CcSEcCtD
Temazepam—CYP2B6—female reproductive system—ovarian cancer	0.00211	0.00979	CbGeAlD
Temazepam—Constipation—Topotecan—ovarian cancer	0.00211	0.00371	CcSEcCtD
Temazepam—Decreased appetite—Melphalan—ovarian cancer	0.0021	0.0037	CcSEcCtD
Temazepam—CYP2C9—female reproductive system—ovarian cancer	0.00209	0.00969	CbGeAlD
Temazepam—Cramps of lower extremities—Epirubicin—ovarian cancer	0.00209	0.00368	CcSEcCtD
Temazepam—Fatigue—Melphalan—ovarian cancer	0.00208	0.00367	CcSEcCtD
Temazepam—Abnormal dreams—Doxorubicin—ovarian cancer	0.00208	0.00366	CcSEcCtD
Temazepam—Coma—Epirubicin—ovarian cancer	0.00208	0.00366	CcSEcCtD
Temazepam—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00206	0.00364	CcSEcCtD
Temazepam—Tachycardia—Vinorelbine—ovarian cancer	0.00206	0.00363	CcSEcCtD
Temazepam—Hypersensitivity—Chlorambucil—ovarian cancer	0.00204	0.00359	CcSEcCtD
Temazepam—Feeling abnormal—Topotecan—ovarian cancer	0.00203	0.00358	CcSEcCtD
Temazepam—Anorexia—Vinorelbine—ovarian cancer	0.00201	0.00354	CcSEcCtD
Temazepam—TSPO—lymph node—ovarian cancer	0.00201	0.0093	CbGeAlD
Temazepam—Asthenia—Chlorambucil—ovarian cancer	0.00199	0.0035	CcSEcCtD
Temazepam—Hypotension—Vinorelbine—ovarian cancer	0.00197	0.00347	CcSEcCtD
Temazepam—Pruritus—Chlorambucil—ovarian cancer	0.00196	0.00345	CcSEcCtD
Temazepam—Cramps of lower extremities—Doxorubicin—ovarian cancer	0.00193	0.0034	CcSEcCtD
Temazepam—Visual impairment—Paclitaxel—ovarian cancer	0.00192	0.00339	CcSEcCtD
Temazepam—Coma—Doxorubicin—ovarian cancer	0.00192	0.00339	CcSEcCtD
Temazepam—CYP2B6—vagina—ovarian cancer	0.00191	0.00885	CbGeAlD
Temazepam—CYP2C8—testis—ovarian cancer	0.0019	0.0088	CbGeAlD
Temazepam—Blood alkaline phosphatase increased—Epirubicin—ovarian cancer	0.0019	0.00334	CcSEcCtD
Temazepam—Diarrhoea—Chlorambucil—ovarian cancer	0.00189	0.00334	CcSEcCtD
Temazepam—Dyspnoea—Vinorelbine—ovarian cancer	0.00188	0.00331	CcSEcCtD
Temazepam—Jaundice—Docetaxel—ovarian cancer	0.00184	0.00324	CcSEcCtD
Temazepam—Decreased appetite—Vinorelbine—ovarian cancer	0.00183	0.00323	CcSEcCtD
Temazepam—Fatigue—Vinorelbine—ovarian cancer	0.00182	0.0032	CcSEcCtD
Temazepam—Hypersensitivity—Topotecan—ovarian cancer	0.00182	0.0032	CcSEcCtD
Temazepam—Constipation—Vinorelbine—ovarian cancer	0.0018	0.00318	CcSEcCtD
Temazepam—Hypersensitivity—Melphalan—ovarian cancer	0.00178	0.00313	CcSEcCtD
Temazepam—Asthenia—Topotecan—ovarian cancer	0.00177	0.00312	CcSEcCtD
Temazepam—Alopecia—Paclitaxel—ovarian cancer	0.00176	0.00311	CcSEcCtD
Temazepam—Vomiting—Chlorambucil—ovarian cancer	0.00176	0.0031	CcSEcCtD
Temazepam—Agranulocytosis—Docetaxel—ovarian cancer	0.00176	0.0031	CcSEcCtD
Temazepam—Blood alkaline phosphatase increased—Doxorubicin—ovarian cancer	0.00175	0.00309	CcSEcCtD
Temazepam—Pruritus—Topotecan—ovarian cancer	0.00174	0.00307	CcSEcCtD
Temazepam—Feeling abnormal—Vinorelbine—ovarian cancer	0.00174	0.00306	CcSEcCtD
Temazepam—Asthenia—Melphalan—ovarian cancer	0.00173	0.00305	CcSEcCtD
Temazepam—Pruritus—Melphalan—ovarian cancer	0.00171	0.00301	CcSEcCtD
Temazepam—Tension—Paclitaxel—ovarian cancer	0.0017	0.00301	CcSEcCtD
Temazepam—CYP2B6—testis—ovarian cancer	0.0017	0.0079	CbGeAlD
Temazepam—Nervousness—Paclitaxel—ovarian cancer	0.00169	0.00297	CcSEcCtD
Temazepam—Diarrhoea—Topotecan—ovarian cancer	0.00169	0.00297	CcSEcCtD
Temazepam—Lethargy—Epirubicin—ovarian cancer	0.00168	0.00297	CcSEcCtD
Temazepam—Back pain—Paclitaxel—ovarian cancer	0.00168	0.00296	CcSEcCtD
Temazepam—Muscle spasms—Paclitaxel—ovarian cancer	0.00167	0.00294	CcSEcCtD
Temazepam—Hyponatraemia—Epirubicin—ovarian cancer	0.00166	0.00292	CcSEcCtD
Temazepam—Diarrhoea—Melphalan—ovarian cancer	0.00165	0.00291	CcSEcCtD
Temazepam—Diplopia—Epirubicin—ovarian cancer	0.00165	0.00291	CcSEcCtD
Temazepam—Osteoarthritis—Epirubicin—ovarian cancer	0.00165	0.00291	CcSEcCtD
Temazepam—Nausea—Chlorambucil—ovarian cancer	0.00164	0.0029	CcSEcCtD
Temazepam—Vision blurred—Paclitaxel—ovarian cancer	0.00164	0.00289	CcSEcCtD
Temazepam—Visual impairment—Docetaxel—ovarian cancer	0.00163	0.00287	CcSEcCtD
Temazepam—Dizziness—Topotecan—ovarian cancer	0.00163	0.00287	CcSEcCtD
Temazepam—Tremor—Paclitaxel—ovarian cancer	0.00163	0.00287	CcSEcCtD
Temazepam—Agitation—Paclitaxel—ovarian cancer	0.0016	0.00281	CcSEcCtD
Temazepam—CYP3A4—female reproductive system—ovarian cancer	0.00159	0.00739	CbGeAlD
Temazepam—Vomiting—Topotecan—ovarian cancer	0.00157	0.00276	CcSEcCtD
Temazepam—Vertigo—Paclitaxel—ovarian cancer	0.00156	0.00275	CcSEcCtD
Temazepam—Syncope—Paclitaxel—ovarian cancer	0.00156	0.00275	CcSEcCtD
Temazepam—Lethargy—Doxorubicin—ovarian cancer	0.00156	0.00274	CcSEcCtD
Temazepam—Hypersensitivity—Vinorelbine—ovarian cancer	0.00155	0.00274	CcSEcCtD
Temazepam—Ataxia—Epirubicin—ovarian cancer	0.00155	0.00273	CcSEcCtD
Temazepam—Headache—Topotecan—ovarian cancer	0.00154	0.00272	CcSEcCtD
Temazepam—Palpitations—Paclitaxel—ovarian cancer	0.00154	0.00271	CcSEcCtD
Temazepam—Vomiting—Melphalan—ovarian cancer	0.00153	0.0027	CcSEcCtD
Temazepam—Hyponatraemia—Doxorubicin—ovarian cancer	0.00153	0.0027	CcSEcCtD
Temazepam—Loss of consciousness—Paclitaxel—ovarian cancer	0.00153	0.00269	CcSEcCtD
Temazepam—Osteoarthritis—Doxorubicin—ovarian cancer	0.00153	0.00269	CcSEcCtD
Temazepam—Diplopia—Doxorubicin—ovarian cancer	0.00153	0.00269	CcSEcCtD
Temazepam—Asthenia—Vinorelbine—ovarian cancer	0.00151	0.00267	CcSEcCtD
Temazepam—Convulsion—Paclitaxel—ovarian cancer	0.00151	0.00265	CcSEcCtD
Temazepam—Alopecia—Docetaxel—ovarian cancer	0.00149	0.00263	CcSEcCtD
Temazepam—Pruritus—Vinorelbine—ovarian cancer	0.00149	0.00263	CcSEcCtD
Temazepam—Anxiety—Paclitaxel—ovarian cancer	0.00147	0.0026	CcSEcCtD
Temazepam—Nausea—Topotecan—ovarian cancer	0.00146	0.00258	CcSEcCtD
Temazepam—Dry mouth—Paclitaxel—ovarian cancer	0.00145	0.00255	CcSEcCtD
Temazepam—Diarrhoea—Vinorelbine—ovarian cancer	0.00144	0.00254	CcSEcCtD
Temazepam—Ataxia—Doxorubicin—ovarian cancer	0.00143	0.00253	CcSEcCtD
Temazepam—Nausea—Melphalan—ovarian cancer	0.00143	0.00253	CcSEcCtD
Temazepam—Confusional state—Paclitaxel—ovarian cancer	0.00143	0.00252	CcSEcCtD
Temazepam—Back pain—Docetaxel—ovarian cancer	0.00142	0.00251	CcSEcCtD
Temazepam—Muscle spasms—Docetaxel—ovarian cancer	0.00142	0.0025	CcSEcCtD
Temazepam—Shock—Paclitaxel—ovarian cancer	0.00139	0.00246	CcSEcCtD
Temazepam—Dizziness—Vinorelbine—ovarian cancer	0.00139	0.00246	CcSEcCtD
Temazepam—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00139	0.00245	CcSEcCtD
Temazepam—Tachycardia—Paclitaxel—ovarian cancer	0.00138	0.00244	CcSEcCtD
Temazepam—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00137	0.00242	CcSEcCtD
Temazepam—Anorexia—Paclitaxel—ovarian cancer	0.00135	0.00238	CcSEcCtD
Temazepam—Vomiting—Vinorelbine—ovarian cancer	0.00134	0.00236	CcSEcCtD
Temazepam—Hypotension—Paclitaxel—ovarian cancer	0.00132	0.00234	CcSEcCtD
Temazepam—Headache—Vinorelbine—ovarian cancer	0.00132	0.00233	CcSEcCtD
Temazepam—Syncope—Docetaxel—ovarian cancer	0.00132	0.00233	CcSEcCtD
Temazepam—Palpitations—Docetaxel—ovarian cancer	0.0013	0.00229	CcSEcCtD
Temazepam—Loss of consciousness—Docetaxel—ovarian cancer	0.00129	0.00228	CcSEcCtD
Temazepam—Convulsion—Docetaxel—ovarian cancer	0.00128	0.00225	CcSEcCtD
Temazepam—Drowsiness—Epirubicin—ovarian cancer	0.00127	0.00224	CcSEcCtD
Temazepam—Dyspnoea—Paclitaxel—ovarian cancer	0.00126	0.00223	CcSEcCtD
Temazepam—Somnolence—Paclitaxel—ovarian cancer	0.00126	0.00222	CcSEcCtD
Temazepam—Nausea—Vinorelbine—ovarian cancer	0.00125	0.00221	CcSEcCtD
Temazepam—Jaundice—Epirubicin—ovarian cancer	0.00124	0.00218	CcSEcCtD
Temazepam—Decreased appetite—Paclitaxel—ovarian cancer	0.00123	0.00217	CcSEcCtD
Temazepam—Dry mouth—Docetaxel—ovarian cancer	0.00123	0.00216	CcSEcCtD
Temazepam—Fatigue—Paclitaxel—ovarian cancer	0.00122	0.00215	CcSEcCtD
Temazepam—Constipation—Paclitaxel—ovarian cancer	0.00121	0.00214	CcSEcCtD
Temazepam—Confusional state—Docetaxel—ovarian cancer	0.00121	0.00214	CcSEcCtD
Temazepam—Agranulocytosis—Epirubicin—ovarian cancer	0.00119	0.00209	CcSEcCtD
Temazepam—Shock—Docetaxel—ovarian cancer	0.00118	0.00208	CcSEcCtD
Temazepam—Thrombocytopenia—Docetaxel—ovarian cancer	0.00118	0.00207	CcSEcCtD
Temazepam—Drowsiness—Doxorubicin—ovarian cancer	0.00118	0.00207	CcSEcCtD
Temazepam—Tachycardia—Docetaxel—ovarian cancer	0.00117	0.00207	CcSEcCtD
Temazepam—Feeling abnormal—Paclitaxel—ovarian cancer	0.00117	0.00206	CcSEcCtD
Temazepam—Jaundice—Doxorubicin—ovarian cancer	0.00115	0.00202	CcSEcCtD
Temazepam—Anorexia—Docetaxel—ovarian cancer	0.00115	0.00202	CcSEcCtD
Temazepam—Hypotension—Docetaxel—ovarian cancer	0.00112	0.00198	CcSEcCtD
Temazepam—Visual impairment—Epirubicin—ovarian cancer	0.0011	0.00194	CcSEcCtD
Temazepam—Agranulocytosis—Doxorubicin—ovarian cancer	0.0011	0.00193	CcSEcCtD
Temazepam—Dyspnoea—Docetaxel—ovarian cancer	0.00107	0.00189	CcSEcCtD
Temazepam—Somnolence—Docetaxel—ovarian cancer	0.00107	0.00188	CcSEcCtD
Temazepam—Decreased appetite—Docetaxel—ovarian cancer	0.00104	0.00184	CcSEcCtD
Temazepam—Hypersensitivity—Paclitaxel—ovarian cancer	0.00104	0.00184	CcSEcCtD
Temazepam—Fatigue—Docetaxel—ovarian cancer	0.00104	0.00183	CcSEcCtD
Temazepam—Constipation—Docetaxel—ovarian cancer	0.00103	0.00181	CcSEcCtD
Temazepam—Visual impairment—Doxorubicin—ovarian cancer	0.00102	0.00179	CcSEcCtD
Temazepam—Asthenia—Paclitaxel—ovarian cancer	0.00102	0.00179	CcSEcCtD
Temazepam—Alopecia—Epirubicin—ovarian cancer	0.00101	0.00178	CcSEcCtD
Temazepam—Pruritus—Paclitaxel—ovarian cancer	0.001	0.00177	CcSEcCtD
Temazepam—Feeling abnormal—Docetaxel—ovarian cancer	0.00099	0.00175	CcSEcCtD
Temazepam—Tension—Epirubicin—ovarian cancer	0.000975	0.00172	CcSEcCtD
Temazepam—Diarrhoea—Paclitaxel—ovarian cancer	0.00097	0.00171	CcSEcCtD
Temazepam—Nervousness—Epirubicin—ovarian cancer	0.000965	0.0017	CcSEcCtD
Temazepam—Back pain—Epirubicin—ovarian cancer	0.000961	0.00169	CcSEcCtD
Temazepam—Muscle spasms—Epirubicin—ovarian cancer	0.000955	0.00168	CcSEcCtD
Temazepam—Dizziness—Paclitaxel—ovarian cancer	0.000938	0.00165	CcSEcCtD
Temazepam—Vision blurred—Epirubicin—ovarian cancer	0.000936	0.00165	CcSEcCtD
Temazepam—Alopecia—Doxorubicin—ovarian cancer	0.000933	0.00164	CcSEcCtD
Temazepam—Agitation—Epirubicin—ovarian cancer	0.000913	0.00161	CcSEcCtD
Temazepam—Tension—Doxorubicin—ovarian cancer	0.000902	0.00159	CcSEcCtD
Temazepam—Vomiting—Paclitaxel—ovarian cancer	0.000901	0.00159	CcSEcCtD
Temazepam—Nervousness—Doxorubicin—ovarian cancer	0.000893	0.00157	CcSEcCtD
Temazepam—Vertigo—Epirubicin—ovarian cancer	0.000892	0.00157	CcSEcCtD
Temazepam—Syncope—Epirubicin—ovarian cancer	0.000891	0.00157	CcSEcCtD
Temazepam—Back pain—Doxorubicin—ovarian cancer	0.000889	0.00157	CcSEcCtD
Temazepam—Headache—Paclitaxel—ovarian cancer	0.000888	0.00157	CcSEcCtD
Temazepam—Hypersensitivity—Docetaxel—ovarian cancer	0.000885	0.00156	CcSEcCtD
Temazepam—Muscle spasms—Doxorubicin—ovarian cancer	0.000884	0.00156	CcSEcCtD
Temazepam—Palpitations—Epirubicin—ovarian cancer	0.000878	0.00155	CcSEcCtD
Temazepam—Loss of consciousness—Epirubicin—ovarian cancer	0.000873	0.00154	CcSEcCtD
Temazepam—Vision blurred—Doxorubicin—ovarian cancer	0.000866	0.00153	CcSEcCtD
Temazepam—Asthenia—Docetaxel—ovarian cancer	0.000862	0.00152	CcSEcCtD
Temazepam—Convulsion—Epirubicin—ovarian cancer	0.000861	0.00152	CcSEcCtD
Temazepam—Pruritus—Docetaxel—ovarian cancer	0.00085	0.0015	CcSEcCtD
Temazepam—Agitation—Doxorubicin—ovarian cancer	0.000845	0.00149	CcSEcCtD
Temazepam—Anxiety—Epirubicin—ovarian cancer	0.000843	0.00149	CcSEcCtD
Temazepam—Nausea—Paclitaxel—ovarian cancer	0.000842	0.00148	CcSEcCtD
Temazepam—Dry mouth—Epirubicin—ovarian cancer	0.000827	0.00146	CcSEcCtD
Temazepam—Vertigo—Doxorubicin—ovarian cancer	0.000826	0.00146	CcSEcCtD
Temazepam—Clozapine—CYP1B1—ovarian cancer	0.000824	0.233	CrCbGaD
Temazepam—Syncope—Doxorubicin—ovarian cancer	0.000824	0.00145	CcSEcCtD
Temazepam—Diarrhoea—Docetaxel—ovarian cancer	0.000822	0.00145	CcSEcCtD
Temazepam—Confusional state—Epirubicin—ovarian cancer	0.000817	0.00144	CcSEcCtD
Temazepam—Palpitations—Doxorubicin—ovarian cancer	0.000812	0.00143	CcSEcCtD
Temazepam—Loss of consciousness—Doxorubicin—ovarian cancer	0.000808	0.00142	CcSEcCtD
Temazepam—Shock—Epirubicin—ovarian cancer	0.000797	0.00141	CcSEcCtD
Temazepam—Convulsion—Doxorubicin—ovarian cancer	0.000796	0.0014	CcSEcCtD
Temazepam—Dizziness—Docetaxel—ovarian cancer	0.000795	0.0014	CcSEcCtD
Temazepam—Thrombocytopenia—Epirubicin—ovarian cancer	0.000794	0.0014	CcSEcCtD
Temazepam—Tachycardia—Epirubicin—ovarian cancer	0.000791	0.00139	CcSEcCtD
Temazepam—Hyperhidrosis—Epirubicin—ovarian cancer	0.000784	0.00138	CcSEcCtD
Temazepam—Anxiety—Doxorubicin—ovarian cancer	0.00078	0.00137	CcSEcCtD
Temazepam—Anorexia—Epirubicin—ovarian cancer	0.000773	0.00136	CcSEcCtD
Temazepam—Dry mouth—Doxorubicin—ovarian cancer	0.000765	0.00135	CcSEcCtD
Temazepam—Vomiting—Docetaxel—ovarian cancer	0.000764	0.00135	CcSEcCtD
Temazepam—Hypotension—Epirubicin—ovarian cancer	0.000757	0.00134	CcSEcCtD
Temazepam—Confusional state—Doxorubicin—ovarian cancer	0.000756	0.00133	CcSEcCtD
Temazepam—Headache—Docetaxel—ovarian cancer	0.000753	0.00133	CcSEcCtD
Temazepam—Shock—Doxorubicin—ovarian cancer	0.000738	0.0013	CcSEcCtD
Temazepam—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000734	0.00129	CcSEcCtD
Temazepam—Tachycardia—Doxorubicin—ovarian cancer	0.000732	0.00129	CcSEcCtD
Temazepam—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000725	0.00128	CcSEcCtD
Temazepam—Dyspnoea—Epirubicin—ovarian cancer	0.000723	0.00127	CcSEcCtD
Temazepam—Somnolence—Epirubicin—ovarian cancer	0.000721	0.00127	CcSEcCtD
Temazepam—Anorexia—Doxorubicin—ovarian cancer	0.000715	0.00126	CcSEcCtD
Temazepam—Nausea—Docetaxel—ovarian cancer	0.000714	0.00126	CcSEcCtD
Temazepam—Decreased appetite—Epirubicin—ovarian cancer	0.000705	0.00124	CcSEcCtD
Temazepam—Hypotension—Doxorubicin—ovarian cancer	0.000701	0.00124	CcSEcCtD
Temazepam—Fatigue—Epirubicin—ovarian cancer	0.000699	0.00123	CcSEcCtD
Temazepam—Constipation—Epirubicin—ovarian cancer	0.000693	0.00122	CcSEcCtD
Temazepam—Dyspnoea—Doxorubicin—ovarian cancer	0.000669	0.00118	CcSEcCtD
Temazepam—Feeling abnormal—Epirubicin—ovarian cancer	0.000668	0.00118	CcSEcCtD
Temazepam—Somnolence—Doxorubicin—ovarian cancer	0.000667	0.00118	CcSEcCtD
Temazepam—Decreased appetite—Doxorubicin—ovarian cancer	0.000652	0.00115	CcSEcCtD
Temazepam—Fatigue—Doxorubicin—ovarian cancer	0.000647	0.00114	CcSEcCtD
Temazepam—Constipation—Doxorubicin—ovarian cancer	0.000641	0.00113	CcSEcCtD
Temazepam—Feeling abnormal—Doxorubicin—ovarian cancer	0.000618	0.00109	CcSEcCtD
Temazepam—Hypersensitivity—Epirubicin—ovarian cancer	0.000597	0.00105	CcSEcCtD
Temazepam—Asthenia—Epirubicin—ovarian cancer	0.000582	0.00103	CcSEcCtD
Temazepam—Ketazolam—ABCB1—ovarian cancer	0.000581	0.164	CrCbGaD
Temazepam—Pruritus—Epirubicin—ovarian cancer	0.000573	0.00101	CcSEcCtD
Temazepam—Diarrhoea—Epirubicin—ovarian cancer	0.000555	0.000978	CcSEcCtD
Temazepam—Hypersensitivity—Doxorubicin—ovarian cancer	0.000553	0.000974	CcSEcCtD
Temazepam—Asthenia—Doxorubicin—ovarian cancer	0.000538	0.000949	CcSEcCtD
Temazepam—Dizziness—Epirubicin—ovarian cancer	0.000536	0.000945	CcSEcCtD
Temazepam—Pruritus—Doxorubicin—ovarian cancer	0.000531	0.000935	CcSEcCtD
Temazepam—Vomiting—Epirubicin—ovarian cancer	0.000515	0.000908	CcSEcCtD
Temazepam—Diarrhoea—Doxorubicin—ovarian cancer	0.000513	0.000905	CcSEcCtD
Temazepam—Headache—Epirubicin—ovarian cancer	0.000508	0.000895	CcSEcCtD
Temazepam—Dizziness—Doxorubicin—ovarian cancer	0.000496	0.000874	CcSEcCtD
Temazepam—Nausea—Epirubicin—ovarian cancer	0.000481	0.000849	CcSEcCtD
Temazepam—Vomiting—Doxorubicin—ovarian cancer	0.000477	0.000841	CcSEcCtD
Temazepam—Headache—Doxorubicin—ovarian cancer	0.00047	0.000828	CcSEcCtD
Temazepam—Nausea—Doxorubicin—ovarian cancer	0.000446	0.000785	CcSEcCtD
Temazepam—Clobazam—ABCB1—ovarian cancer	0.00041	0.116	CrCbGaD
Temazepam—Nitrazepam—ABCB1—ovarian cancer	0.000339	0.096	CrCbGaD
Temazepam—Chlorprothixene—ABCB1—ovarian cancer	0.000323	0.0914	CrCbGaD
Temazepam—Flurazepam—ABCB1—ovarian cancer	0.000302	0.0853	CrCbGaD
Temazepam—Midazolam—ABCB1—ovarian cancer	0.00028	0.0791	CrCbGaD
Temazepam—Diazepam—ABCB1—ovarian cancer	0.00024	0.0678	CrCbGaD
Temazepam—Clozapine—ABCB1—ovarian cancer	0.000237	0.0669	CrCbGaD
Temazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000121	0.00127	CbGpPWpGaD
Temazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000121	0.00127	CbGpPWpGaD
Temazepam—GABRQ—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.00012	0.00127	CbGpPWpGaD
Temazepam—GABRR2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.00012	0.00127	CbGpPWpGaD
Temazepam—GABRB3—BDNF signaling pathway—CTNNB1—ovarian cancer	0.00012	0.00126	CbGpPWpGaD
Temazepam—GABRA4—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000119	0.00126	CbGpPWpGaD
Temazepam—GABRR1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000118	0.00125	CbGpPWpGaD
Temazepam—GABRA6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000117	0.00123	CbGpPWpGaD
Temazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000115	0.00122	CbGpPWpGaD
Temazepam—GABRA4—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000115	0.00122	CbGpPWpGaD
Temazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000114	0.0012	CbGpPWpGaD
Temazepam—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	0.000114	0.0012	CbGpPWpGaD
Temazepam—GABRR2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000113	0.00119	CbGpPWpGaD
Temazepam—GABRQ—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000113	0.00119	CbGpPWpGaD
Temazepam—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000112	0.00118	CbGpPWpGaD
Temazepam—GABRB2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000109	0.00115	CbGpPWpGaD
Temazepam—GABRA5—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000106	0.00112	CbGpPWpGaD
Temazepam—GABRB2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000105	0.00111	CbGpPWpGaD
Temazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000104	0.0011	CbGpPWpGaD
Temazepam—GABRB3—BDNF signaling pathway—STAT3—ovarian cancer	0.000104	0.0011	CbGpPWpGaD
Temazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000104	0.0011	CbGpPWpGaD
Temazepam—GABRA3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000104	0.0011	CbGpPWpGaD
Temazepam—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	0.000104	0.00109	CbGpPWpGaD
Temazepam—GABRA5—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000102	0.00108	CbGpPWpGaD
Temazepam—GABRA2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000102	0.00108	CbGpPWpGaD
Temazepam—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000102	0.00108	CbGpPWpGaD
Temazepam—GABRB3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000101	0.00107	CbGpPWpGaD
Temazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000101	0.00107	CbGpPWpGaD
Temazepam—GABRA3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.0001	0.00106	CbGpPWpGaD
Temazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	9.99e-05	0.00106	CbGpPWpGaD
Temazepam—GABRG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	9.97e-05	0.00105	CbGpPWpGaD
Temazepam—GABRB3—BDNF signaling pathway—MAPK3—ovarian cancer	9.96e-05	0.00105	CbGpPWpGaD
Temazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	9.93e-05	0.00105	CbGpPWpGaD
Temazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	9.93e-05	0.00105	CbGpPWpGaD
Temazepam—GABRG3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.87e-05	0.00104	CbGpPWpGaD
Temazepam—GABRA2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	9.87e-05	0.00104	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	9.81e-05	0.00104	CbGpPWpGaD
Temazepam—GABRB3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	9.8e-05	0.00104	CbGpPWpGaD
Temazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	9.78e-05	0.00103	CbGpPWpGaD
Temazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	9.76e-05	0.00103	CbGpPWpGaD
Temazepam—GABRB1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.72e-05	0.00103	CbGpPWpGaD
Temazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	9.7e-05	0.00102	CbGpPWpGaD
Temazepam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	9.63e-05	0.00102	CbGpPWpGaD
Temazepam—GABRG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	9.63e-05	0.00102	CbGpPWpGaD
Temazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	9.52e-05	0.00101	CbGpPWpGaD
Temazepam—GABRR1—Transmission across Chemical Synapses—HRAS—ovarian cancer	9.5e-05	0.001	CbGpPWpGaD
Temazepam—GABRB3—BDNF signaling pathway—MAPK1—ovarian cancer	9.48e-05	0.001	CbGpPWpGaD
Temazepam—GABRG3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	9.3e-05	0.000982	CbGpPWpGaD
Temazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	9.26e-05	0.000978	CbGpPWpGaD
Temazepam—GABRA6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.2e-05	0.000972	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—NME2—ovarian cancer	9.16e-05	0.000967	CbGpPWpGaD
Temazepam—GABRB1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	9.16e-05	0.000967	CbGpPWpGaD
Temazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	9.14e-05	0.000965	CbGpPWpGaD
Temazepam—GABRA4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.08e-05	0.00096	CbGpPWpGaD
Temazepam—GABRR1—Neuronal System—MAPK1—ovarian cancer	9.07e-05	0.000958	CbGpPWpGaD
Temazepam—GABRQ—Transmission across Chemical Synapses—HRAS—ovarian cancer	9.06e-05	0.000957	CbGpPWpGaD
Temazepam—GABRR2—Transmission across Chemical Synapses—HRAS—ovarian cancer	9.06e-05	0.000957	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	8.75e-05	0.000925	CbGpPWpGaD
Temazepam—GABRA1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	8.71e-05	0.00092	CbGpPWpGaD
Temazepam—GABRA6—Transmission across Chemical Synapses—MAPK1—ovarian cancer	8.67e-05	0.000915	CbGpPWpGaD
Temazepam—GABRR2—Neuronal System—MAPK1—ovarian cancer	8.65e-05	0.000914	CbGpPWpGaD
Temazepam—GABRQ—Neuronal System—MAPK1—ovarian cancer	8.65e-05	0.000914	CbGpPWpGaD
Temazepam—GABRA4—Transmission across Chemical Synapses—MAPK1—ovarian cancer	8.56e-05	0.000904	CbGpPWpGaD
Temazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	8.48e-05	0.000896	CbGpPWpGaD
Temazepam—GABRA1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	8.41e-05	0.000889	CbGpPWpGaD
Temazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	8.36e-05	0.000883	CbGpPWpGaD
Temazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	8.32e-05	0.000879	CbGpPWpGaD
Temazepam—GABRB2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	8.31e-05	0.000878	CbGpPWpGaD
Temazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	8.12e-05	0.000858	CbGpPWpGaD
Temazepam—GABRA5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	8.07e-05	0.000853	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	7.98e-05	0.000843	CbGpPWpGaD
Temazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	7.97e-05	0.000842	CbGpPWpGaD
Temazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	7.93e-05	0.000837	CbGpPWpGaD
Temazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	7.84e-05	0.000828	CbGpPWpGaD
Temazepam—GABRB2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	7.83e-05	0.000827	CbGpPWpGaD
Temazepam—GABRA2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	7.79e-05	0.000823	CbGpPWpGaD
Temazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	7.78e-05	0.000822	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—NME2—ovarian cancer	7.75e-05	0.000819	CbGpPWpGaD
Temazepam—GABRB3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	7.74e-05	0.000817	CbGpPWpGaD
Temazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	7.64e-05	0.000807	CbGpPWpGaD
Temazepam—GABRB3—BDNF signaling pathway—HRAS—ovarian cancer	7.61e-05	0.000804	CbGpPWpGaD
Temazepam—GABRA5—Transmission across Chemical Synapses—MAPK1—ovarian cancer	7.6e-05	0.000803	CbGpPWpGaD
Temazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	7.6e-05	0.000803	CbGpPWpGaD
Temazepam—GABRA3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	7.47e-05	0.000789	CbGpPWpGaD
Temazepam—GABRG3—Transmission across Chemical Synapses—HRAS—ovarian cancer	7.46e-05	0.000788	CbGpPWpGaD
Temazepam—GABRB1—Transmission across Chemical Synapses—HRAS—ovarian cancer	7.35e-05	0.000777	CbGpPWpGaD
Temazepam—GABRA2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	7.34e-05	0.000775	CbGpPWpGaD
Temazepam—GABRB3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	7.29e-05	0.00077	CbGpPWpGaD
Temazepam—GABRR1—Neuronal System—HRAS—ovarian cancer	7.28e-05	0.000769	CbGpPWpGaD
Temazepam—GABRG2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	7.16e-05	0.000756	CbGpPWpGaD
Temazepam—GABRG3—Neuronal System—MAPK1—ovarian cancer	7.12e-05	0.000752	CbGpPWpGaD
Temazepam—GABRB1—Neuronal System—MAPK1—ovarian cancer	7.02e-05	0.000741	CbGpPWpGaD
Temazepam—GABRA6—Transmission across Chemical Synapses—HRAS—ovarian cancer	6.96e-05	0.000735	CbGpPWpGaD
Temazepam—GABRQ—Neuronal System—HRAS—ovarian cancer	6.95e-05	0.000734	CbGpPWpGaD
Temazepam—GABRR2—Neuronal System—HRAS—ovarian cancer	6.95e-05	0.000734	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—NME2—ovarian cancer	6.92e-05	0.000731	CbGpPWpGaD
Temazepam—GABRA4—Transmission across Chemical Synapses—HRAS—ovarian cancer	6.87e-05	0.000726	CbGpPWpGaD
Temazepam—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	6.83e-05	0.000721	CbGpPWpGaD
Temazepam—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	6.73e-05	0.000711	CbGpPWpGaD
Temazepam—GABRB3—BDNF signaling pathway—AKT1—ovarian cancer	6.72e-05	0.00071	CbGpPWpGaD
Temazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	6.68e-05	0.000706	CbGpPWpGaD
Temazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	6.64e-05	0.000702	CbGpPWpGaD
Temazepam—GABRA6—Neuronal System—MAPK1—ovarian cancer	6.64e-05	0.000701	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	6.58e-05	0.000695	CbGpPWpGaD
Temazepam—GABRA4—Neuronal System—MAPK1—ovarian cancer	6.56e-05	0.000693	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—NME2—ovarian cancer	6.31e-05	0.000667	CbGpPWpGaD
Temazepam—GABRB2—Transmission across Chemical Synapses—HRAS—ovarian cancer	6.28e-05	0.000664	CbGpPWpGaD
Temazepam—GABRA1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	6.26e-05	0.000661	CbGpPWpGaD
Temazepam—GABRA5—Transmission across Chemical Synapses—HRAS—ovarian cancer	6.1e-05	0.000645	CbGpPWpGaD
Temazepam—GABRB2—Neuronal System—MAPK1—ovarian cancer	6e-05	0.000633	CbGpPWpGaD
Temazepam—GABRA3—Transmission across Chemical Synapses—HRAS—ovarian cancer	5.99e-05	0.000633	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—CYTB—ovarian cancer	5.9e-05	0.000623	CbGpPWpGaD
Temazepam—GABRA2—Transmission across Chemical Synapses—HRAS—ovarian cancer	5.89e-05	0.000622	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	5.87e-05	0.00062	CbGpPWpGaD
Temazepam—GABRA1—SIDS Susceptibility Pathways—IL6—ovarian cancer	5.86e-05	0.000619	CbGpPWpGaD
Temazepam—GABRB3—Transmission across Chemical Synapses—HRAS—ovarian cancer	5.85e-05	0.000618	CbGpPWpGaD
Temazepam—GABRA5—Neuronal System—MAPK1—ovarian cancer	5.83e-05	0.000615	CbGpPWpGaD
Temazepam—GABRG2—Transmission across Chemical Synapses—HRAS—ovarian cancer	5.75e-05	0.000607	CbGpPWpGaD
Temazepam—GABRA3—Neuronal System—MAPK1—ovarian cancer	5.72e-05	0.000604	CbGpPWpGaD
Temazepam—GABRG3—Neuronal System—HRAS—ovarian cancer	5.72e-05	0.000604	CbGpPWpGaD
Temazepam—GABRB1—Neuronal System—HRAS—ovarian cancer	5.63e-05	0.000595	CbGpPWpGaD
Temazepam—GABRA2—Neuronal System—MAPK1—ovarian cancer	5.62e-05	0.000594	CbGpPWpGaD
Temazepam—GABRB3—Neuronal System—MAPK1—ovarian cancer	5.59e-05	0.00059	CbGpPWpGaD
Temazepam—GABRG2—Neuronal System—MAPK1—ovarian cancer	5.48e-05	0.000579	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	5.36e-05	0.000566	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	5.35e-05	0.000565	CbGpPWpGaD
Temazepam—GABRA6—Neuronal System—HRAS—ovarian cancer	5.33e-05	0.000563	CbGpPWpGaD
Temazepam—GABRA4—Neuronal System—HRAS—ovarian cancer	5.26e-05	0.000556	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—BRIP1—ovarian cancer	5.16e-05	0.000545	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—PPP1CC—ovarian cancer	5.16e-05	0.000545	CbGpPWpGaD
Temazepam—GABRA1—Transmission across Chemical Synapses—HRAS—ovarian cancer	5.02e-05	0.000531	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—CYTB—ovarian cancer	5e-05	0.000528	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4.88e-05	0.000516	CbGpPWpGaD
Temazepam—GABRB2—Neuronal System—HRAS—ovarian cancer	4.81e-05	0.000508	CbGpPWpGaD
Temazepam—GABRA1—Neuronal System—MAPK1—ovarian cancer	4.79e-05	0.000506	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	4.79e-05	0.000506	CbGpPWpGaD
Temazepam—GABRA5—Neuronal System—HRAS—ovarian cancer	4.68e-05	0.000494	CbGpPWpGaD
Temazepam—GABRA3—Neuronal System—HRAS—ovarian cancer	4.59e-05	0.000485	CbGpPWpGaD
Temazepam—GABRA2—Neuronal System—HRAS—ovarian cancer	4.51e-05	0.000477	CbGpPWpGaD
Temazepam—GABRB3—Neuronal System—HRAS—ovarian cancer	4.48e-05	0.000474	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—CYTB—ovarian cancer	4.46e-05	0.000471	CbGpPWpGaD
Temazepam—GABRG2—Neuronal System—HRAS—ovarian cancer	4.4e-05	0.000465	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—PPP1CC—ovarian cancer	4.37e-05	0.000461	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—BRIP1—ovarian cancer	4.37e-05	0.000461	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	4.36e-05	0.000461	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4.36e-05	0.00046	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—NME2—ovarian cancer	4.16e-05	0.00044	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—CYTB—ovarian cancer	4.07e-05	0.00043	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.97e-05	0.00042	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—PPP1CC—ovarian cancer	3.9e-05	0.000412	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—BRIP1—ovarian cancer	3.9e-05	0.000412	CbGpPWpGaD
Temazepam—GABRA1—Neuronal System—HRAS—ovarian cancer	3.85e-05	0.000407	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—PPP1CC—ovarian cancer	3.55e-05	0.000375	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—BRIP1—ovarian cancer	3.55e-05	0.000375	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—YAP1—ovarian cancer	3.46e-05	0.000365	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.18e-05	0.000336	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—YAP1—ovarian cancer	2.93e-05	0.000309	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.9e-05	0.000306	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.84e-05	0.0003	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—FASN—ovarian cancer	2.82e-05	0.000298	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—SLC5A5—ovarian cancer	2.77e-05	0.000293	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—CYTB—ovarian cancer	2.68e-05	0.000283	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—SLC2A1—ovarian cancer	2.68e-05	0.000283	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—YAP1—ovarian cancer	2.61e-05	0.000276	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.59e-05	0.000274	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.59e-05	0.000273	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—CYP1B1—ovarian cancer	2.57e-05	0.000271	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.55e-05	0.000269	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—FASN—ovarian cancer	2.39e-05	0.000252	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—YAP1—ovarian cancer	2.38e-05	0.000252	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.36e-05	0.000249	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—SLC5A5—ovarian cancer	2.35e-05	0.000248	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—BRIP1—ovarian cancer	2.34e-05	0.000248	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—PPP1CC—ovarian cancer	2.34e-05	0.000248	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	2.28e-05	0.000241	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.27e-05	0.00024	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—SLC2A1—ovarian cancer	2.27e-05	0.00024	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.22e-05	0.000235	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—CYP1B1—ovarian cancer	2.18e-05	0.00023	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—FASN—ovarian cancer	2.13e-05	0.000225	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—ABCB1—ovarian cancer	2.12e-05	0.000223	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—SLC5A5—ovarian cancer	2.1e-05	0.000221	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—TYMS—ovarian cancer	2.08e-05	0.000219	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.07e-05	0.000219	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—SLC2A1—ovarian cancer	2.02e-05	0.000214	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.98e-05	0.000209	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—FASN—ovarian cancer	1.94e-05	0.000205	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—CYP1B1—ovarian cancer	1.94e-05	0.000205	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	1.93e-05	0.000204	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.92e-05	0.000203	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—SLC5A5—ovarian cancer	1.91e-05	0.000202	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—SLC2A1—ovarian cancer	1.85e-05	0.000195	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.81e-05	0.000191	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—ABCB1—ovarian cancer	1.79e-05	0.000189	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—CYP1B1—ovarian cancer	1.77e-05	0.000187	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—TYMS—ovarian cancer	1.76e-05	0.000186	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	1.72e-05	0.000182	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.71e-05	0.000181	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—CAV1—ovarian cancer	1.67e-05	0.000177	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—ABCB1—ovarian cancer	1.6e-05	0.000169	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—YAP1—ovarian cancer	1.57e-05	0.000166	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—TYMS—ovarian cancer	1.57e-05	0.000166	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	1.57e-05	0.000166	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.56e-05	0.000165	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—PIK3CG—ovarian cancer	1.53e-05	0.000161	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—ABCB1—ovarian cancer	1.46e-05	0.000154	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—TYMS—ovarian cancer	1.43e-05	0.000151	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—CAV1—ovarian cancer	1.42e-05	0.00015	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.35e-05	0.000143	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—PIK3CD—ovarian cancer	1.34e-05	0.000142	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—PIK3CG—ovarian cancer	1.29e-05	0.000136	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—FASN—ovarian cancer	1.28e-05	0.000135	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—CAV1—ovarian cancer	1.27e-05	0.000134	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.26e-05	0.000133	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.22e-05	0.000129	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.21e-05	0.000128	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—PIK3CB—ovarian cancer	1.17e-05	0.000123	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.17e-05	0.000123	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—CAV1—ovarian cancer	1.15e-05	0.000122	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—PIK3CG—ovarian cancer	1.15e-05	0.000122	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—PIK3CD—ovarian cancer	1.14e-05	0.00012	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.1e-05	0.000116	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—PIK3CG—ovarian cancer	1.05e-05	0.000111	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.04e-05	0.000109	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—PIK3CD—ovarian cancer	1.01e-05	0.000107	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—PTEN—ovarian cancer	1.01e-05	0.000107	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—PIK3CB—ovarian cancer	9.89e-06	0.000104	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—ABCB1—ovarian cancer	9.61e-06	0.000102	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—TYMS—ovarian cancer	9.44e-06	9.97e-05	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—PIK3CD—ovarian cancer	9.24e-06	9.76e-05	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—PIK3CB—ovarian cancer	8.83e-06	9.33e-05	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—PTEN—ovarian cancer	8.55e-06	9.03e-05	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—PIK3CB—ovarian cancer	8.05e-06	8.5e-05	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—PTEN—ovarian cancer	7.63e-06	8.06e-05	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—CAV1—ovarian cancer	7.61e-06	8.04e-05	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—PIK3CA—ovarian cancer	7.12e-06	7.52e-05	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—PTEN—ovarian cancer	6.96e-06	7.35e-05	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—PIK3CG—ovarian cancer	6.93e-06	7.32e-05	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—PIK3CD—ovarian cancer	6.09e-06	6.43e-05	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—PIK3CA—ovarian cancer	6.03e-06	6.37e-05	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—AKT1—ovarian cancer	5.82e-06	6.15e-05	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—PIK3CA—ovarian cancer	5.38e-06	5.69e-05	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—PIK3CB—ovarian cancer	5.31e-06	5.61e-05	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—AKT1—ovarian cancer	4.93e-06	5.2e-05	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—PIK3CA—ovarian cancer	4.91e-06	5.18e-05	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—PTEN—ovarian cancer	4.59e-06	4.85e-05	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—AKT1—ovarian cancer	4.4e-06	4.64e-05	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—AKT1—ovarian cancer	4.01e-06	4.24e-05	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—PIK3CA—ovarian cancer	3.24e-06	3.42e-05	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—AKT1—ovarian cancer	2.64e-06	2.79e-05	CbGpPWpGaD
